These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 29085492)
1. The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder. Guo C; Xiong D; Yang B; Zhang H; Gu W; Liu M; Yao X; Zheng J; Peng B Oncol Lett; 2017 Oct; 14(4):4857-4862. PubMed ID: 29085492 [TBL] [Abstract][Full Text] [Related]
2. Decreased expression of protein tyrosine phosphatase non-receptor type 12 is involved in the proliferation and recurrence of bladder transitional cell carcinoma. Piao Y; Liu X; Lin Z; Jin Z; Jin X; Yuan K; Wu W Oncol Lett; 2015 Sep; 10(3):1620-1626. PubMed ID: 26622721 [TBL] [Abstract][Full Text] [Related]
3. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression. Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881 [TBL] [Abstract][Full Text] [Related]
4. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof]. Zhou JT; Cai ZM; Li NC; Na YQ Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence. Miyake H; Gleave M; Kamidono S; Hara I Urology; 2002 Jan; 59(1):150-4. PubMed ID: 11796313 [TBL] [Abstract][Full Text] [Related]
6. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro. Aaltonen V; Boström PJ; Söderström KO; Hirvonen O; Tuukkanen J; Nurmi M; Laato M; Peltonen J Am J Pathol; 1999 Mar; 154(3):755-65. PubMed ID: 10079253 [TBL] [Abstract][Full Text] [Related]
7. Elevated prostaglandin E2 level via cPLA2--COX-2--mPGES-1 pathway involved in bladder carcinogenesis induced by terephthalic acid-calculi in Wistar rats. Shi Y; Cui L; Dai G; Chen J; Pan H; Song L; Cheng S; Wang X Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):309-15. PubMed ID: 16621493 [TBL] [Abstract][Full Text] [Related]
8. ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway. Wang Z; Zhao X; Wang W; Liu Y; Li Y; Gao J; Wang C; Zhou M; Liu R; Xu G; Zhou Q Int J Oncol; 2018 Nov; 53(5):2102-2110. PubMed ID: 30106136 [TBL] [Abstract][Full Text] [Related]
9. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma. Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911 [TBL] [Abstract][Full Text] [Related]
10. Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder. Chang S; Lee S; Lee C; Kim JI; Kim Y Urology; 2000 Mar; 55(3):448-52. PubMed ID: 10699635 [TBL] [Abstract][Full Text] [Related]
11. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression. Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057 [TBL] [Abstract][Full Text] [Related]
12. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder. Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870 [TBL] [Abstract][Full Text] [Related]
14. Association between PSCA mRNA expression levels and rs2294008 polymorphism in transitional cell cancer of the bladder. Zheng K; Chen Z; Tian Y; Hao G Oncol Lett; 2015 Feb; 9(2):557-562. PubMed ID: 25624885 [TBL] [Abstract][Full Text] [Related]
15. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder. Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711 [TBL] [Abstract][Full Text] [Related]
16. ZBTB7 overexpression contributes to malignancy in breast cancer. Qu H; Qu D; Chen F; Zhang Z; Liu B; Liu H Cancer Invest; 2010 Jul; 28(6):672-8. PubMed ID: 20394500 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder. Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190 [TBL] [Abstract][Full Text] [Related]
18. Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder. Afsharpad M; Nowroozi MR; Mobasheri MB; Ayati M; Nekoohesh L; Saffari M; Zendehdel K; Modarressi MH Pathol Oncol Res; 2019 Jan; 25(1):191-199. PubMed ID: 29058301 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of flotillin-1 is involved in proliferation and recurrence of bladder transitional cell carcinoma. Guan Y; Song H; Zhang G; Ai X Oncol Rep; 2014 Aug; 32(2):748-54. PubMed ID: 24890092 [TBL] [Abstract][Full Text] [Related]
20. [Expression of melanoma antigen gene in urinary transitional cell carcinomas]. Geng L; Yu LZ; Du P; Ma M; Na YQ Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]